AA
RMD icon

Altman Advisors’s ResMed RMD Stock Holding History

Altman Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,506
Closed -$1.26M – 87
2021
Q1 		$1.26M Sell
6,506
-175
-3% -$35.1K 0.81% 47
2020
Q4 		$1.42M Sell
6,681
-55
-0.8% -$11K 0.89% 49
2020
Q3 		$1.16M Sell
6,736
-5,824
-46% -$1.08M 0.82% 55
2020
Q2 		$2.41M Buy
12,560
+76
+0.6% +$12.4K 2.05% 14
2020
Q1 		$1.84M Buy
+12,484
New +$1.99M 1.71% 26

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Altman Advisors's RMD Position: Q2 2021 in Review

Altman Advisors sold out of ResMed (RMD) in Q2 2021, closing a stake of 6,506 shares — an estimated $1.26M sold.

Altman Advisors first reported a position in RMD in Q1 2020 and held it in 5 quarters. The position peaked at $2.41M in Q2 2020. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Altman Advisors reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Altman Advisors sold 6,506 ResMed shares in Q2 2021, an estimated $1.26M.
  • Altman Advisors first reported a position in ResMed in Q1 2020 and held it in 5 quarters.
  • Altman Advisors's ResMed position peaked at $2.41M in Q2 2020.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Altman Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.